Baricitinib: A Review in Rheumatoid Arthritis

2018/04/23 by Zaina T. Al-Salama, Lesley J. Scott · 26 citations
Medicine · #Adalimumab #Adverse effect #Antifolate #Antimetabolite #Autoimmune and Inflammatory Disorders Research #Chronic Lymphocytic Leukemia Research #Gastroenterology #Internal medicine #Medicine #Methotrexate #Nausea #Population #Rheumatoid Arthritis Research and Therapies #Rheumatoid arthritis

paper · doi:10.1007/s40265-018-0908-4

openalex publication_date 2018/04/23 · openalex created_date 2025/10/10 · openalex updated_date 2026/07/29

Cited by

• Emerging Role of Janus Kinase Inhibitors in Treating Granuloma Annulare: A Clinical, Narrative Review of Efficacy and Safety
• Immunopathogenic Mechanisms and Novel Immune-Modulated Therapies in Rheumatoid Arthritis. [europepmc]
• The anti-viral facet of anti-rheumatic drugs: Lessons from COVID-19. [europepmc]
• Current status of potential therapeutic candidates for the COVID-19 crisis. [europepmc]
• The CoV-2 outbreak: how hematologists could help to fight Covid-19. [europepmc]
• Tackling the cytokine storm in COVID-19, challenges and hopes. [europepmc]
• Unpuzzling COVID-19: tissue-related signaling pathways associated with SARS-CoV-2 infection and transmission. [europepmc]
• Placental transfer and safety in pregnancy of medications under investigation to treat coronavirus disease 2019. [europepmc]
• JAK/STAT pathway in pathology of rheumatoid arthritis (Review). [europepmc]
• Baricitinib Ameliorates Experimental Autoimmune Encephalomyelitis by Modulating the Janus Kinase/Signal Transducer and Activator of Transcription Signaling Pathway. [europepmc]
• Current Status of Baricitinib as a Repurposed Therapy for COVID-19. [europepmc]
• Candidate antiviral drugs for COVID-19 and their environmental implications: a comprehensive analysis. [europepmc]
• JAK inhibitors for asthma. [europepmc]
• Potential Effects of Coronaviruses on the Liver: An Update. [europepmc]
• Calming the cytokine storm of COVID-19 through inhibition of JAK2/STAT3 signaling. [europepmc]
• Mesenchymal Stem Cell-Based Therapy for Rheumatoid Arthritis. [europepmc]
• Nitrile-containing pharmaceuticals: target, mechanism of action, and their SAR studies. [europepmc]
• Double Negative (DN) B cells: A connecting bridge between rheumatic diseases and COVID-19? [europepmc]
• Toward Overcoming Treatment Failure in Rheumatoid Arthritis. [europepmc]
• Baricitinib: A Review in Moderate to Severe Atopic Dermatitis. [europepmc]
• A Comprehensive Overview of Globally Approved JAK Inhibitors. [europepmc]
• JAK: Not Just Another Kinase. [europepmc]
• Signaling pathways in rheumatoid arthritis: implications for targeted therapy. [europepmc]
• Baricitinib Attenuates Bleomycin-Induced Pulmonary Fibrosis in Mice by Inhibiting TGF-β1 Signaling Pathway. [europepmc]
• Targeting strategies for bone diseases: signaling pathways and clinical studies. [europepmc]
• Hepatocellular Carcinoma: Old and Emerging Therapeutic Targets. [europepmc]